SPONSOR
Sumitomo Pharma America, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Hematologic Malignancies
Sumitomo Pharma America, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Hematologic Malignancies.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sumitomo Pharma America, Inc.
How many clinical trials has Sumitomo Pharma America, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Sumitomo Pharma America, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Advanced Hematologic Malignancies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sumitomo Pharma America, Inc. research focus on?
Sumitomo Pharma America, Inc. clinical trials span Advanced Hematologic Malignancies. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sumitomo Pharma America, Inc. clinical trial?
To participate in a Sumitomo Pharma America, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sumitomo Pharma America, Inc. trials with current recruitment status updated daily.
Clinical Trials by Sumitomo Pharma America, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology